These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 36092865)

  • 61. Association between loss of dp140 and cognitive impairment in duchenne and becker dystrophies.
    Chamova T; Guergueltcheva V; Raycheva M; Todorov T; Genova J; Bichev S; Bojinova V; Mitev V; Tournev I; Todorova A
    Balkan J Med Genet; 2013 Jun; 16(1):21-30. PubMed ID: 24265581
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A single NGS-based assay covering the entire genomic sequence of the DMD gene facilitates diagnostic and newborn screening confirmatory testing.
    Nallamilli BRR; Chaubey A; Valencia CA; Stansberry L; Behlmann AM; Ma Z; Mathur A; Shenoy S; Ganapathy V; Jagannathan L; Ramachander V; Ferlini A; Bean L; Hegde M
    Hum Mutat; 2021 May; 42(5):626-638. PubMed ID: 33644936
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Genetic profile of Brazilian patients with dystrophinopathies.
    de Almeida PAD; Machado-Costa MC; Manzoli GN; Ferreira LS; Rodrigues MCS; Bueno LSM; Saute JAM; Pinto Vairo F; Matte US; Siebert M; Cossio SL; Macedo GS; Winckler PB; Becker MM; Magalhães LVB; Gonçalves MVM; Marrone CD; Nucci A; França MC
    Clin Genet; 2017 Aug; 92(2):199-203. PubMed ID: 28116794
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Sequence and Structure Characteristics of 22 Deletion Breakpoints in Intron 44 of the
    Geng C; Tong Y; Zhang S; Ling C; Wu X; Wang D; Dai Y
    Front Genet; 2021; 12():638220. PubMed ID: 34211494
    [No Abstract]   [Full Text] [Related]  

  • 65. [A predictive analysis of the association between clinical phenotypes and genotypes in children with Becker muscular dystrophy/Duchenne muscular dystrophy].
    Niu HH; Tao DY; Cheng SQ
    Zhongguo Dang Dai Er Ke Za Zhi; 2020 Jun; 22(6):602-607. PubMed ID: 32571459
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Identification of a Novel Deep Intronic Mutation in CAPN3 Presenting a Promising Target for Therapeutic Splice Modulation.
    Hu Y; Mohassel P; Donkervoort S; Yun P; Bolduc V; Ezzo D; Dastgir J; Marshall JL; Lek M; MacArthur DG; Foley AR; Bönnemann CG
    J Neuromuscul Dis; 2019; 6(4):475-483. PubMed ID: 31498126
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Precise mapping of 17 deletion breakpoints within the central hotspot deletion region (introns 50 and 51) of the DMD gene.
    Esposito G; Tremolaterra MR; Marsocci E; Tandurella IC; Fioretti T; Savarese M; Carsana A
    J Hum Genet; 2017 Dec; 62(12):1057-1063. PubMed ID: 28878337
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Splicing mutations in DMD/BMD detected by RT-PCR/PTT: detection of a 19AA insertion in the cysteine rich domain of dystrophin compatible with BMD.
    Roest PA; Bout M; van der Tuijn AC; Ginjaar IB; Bakker E; Hogervorst FB; van Ommen GJ; den Dunnen JT
    J Med Genet; 1996 Nov; 33(11):935-9. PubMed ID: 8950674
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Prenatal diagnosis of Duchenne muscular dystrophy revealed a novel mosaic mutation in Dystrophin gene: a case report.
    Wang Y; Chen Y; Wang SM; Liu X; Gu YN; Feng Z
    BMC Med Genet; 2020 Nov; 21(1):222. PubMed ID: 33176713
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Comparison of The Carrier Frequency of Pathogenic Variants of DMD Gene in an Indian Cohort.
    Nagabushana D; Polavarapu K; Bardhan M; Arunachal G; Gunasekaran S; Preethish-Kumar V; Anjanappa RM; Thomas P; Sadasivan A; Vengalil S; Nashi S; Chawla T; Warrier M; Keerthipriya M; Raju S; Mohan D; Nalini A
    J Neuromuscul Dis; 2021; 8(4):525-535. PubMed ID: 33843695
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Strategy for comprehensive molecular testing for Duchenne and Becker muscular dystrophies.
    Stockley TL; Akber S; Bulgin N; Ray PN
    Genet Test; 2006; 10(4):229-43. PubMed ID: 17253928
    [TBL] [Abstract][Full Text] [Related]  

  • 72. MLPA Analyses Reveal a Spectrum of Dystrophin Gene Deletions/Duplications in Pakistani Patients Suspected of Having Duchenne/Becker Muscular Dystrophy: A Retrospective Study.
    Ansar Z; Nasir A; Moatter T; Khan S; Kirmani S; Ibrahim S; Imam K; Ather A; Samreen A; Hasan Z
    Genet Test Mol Biomarkers; 2019 Jul; 23(7):468-472. PubMed ID: 31157985
    [No Abstract]   [Full Text] [Related]  

  • 73. Intronic Alternative Polyadenylation in the Middle of the
    Rani AQM; Yamamoto T; Kawaguchi T; Maeta K; Awano H; Nishio H; Matsuo M
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32443516
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Mutation spectrum of the dystrophin gene in 442 Duchenne/Becker muscular dystrophy cases from one Japanese referral center.
    Takeshima Y; Yagi M; Okizuka Y; Awano H; Zhang Z; Yamauchi Y; Nishio H; Matsuo M
    J Hum Genet; 2010 Jun; 55(6):379-88. PubMed ID: 20485447
    [TBL] [Abstract][Full Text] [Related]  

  • 75. DMDtoolkit: a tool for visualizing the mutated dystrophin protein and predicting the clinical severity in DMD.
    Zhou J; Xin J; Niu Y; Wu S
    BMC Bioinformatics; 2017 Feb; 18(1):87. PubMed ID: 28152980
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Molecular genetic testing and diagnosis strategies for dystrophinopathies in the era of next generation sequencing.
    Zhang K; Yang X; Lin G; Han Y; Li J
    Clin Chim Acta; 2019 Apr; 491():66-73. PubMed ID: 30660698
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The TREAT-NMD DMD Global Database: analysis of more than 7,000 Duchenne muscular dystrophy mutations.
    Bladen CL; Salgado D; Monges S; Foncuberta ME; Kekou K; Kosma K; Dawkins H; Lamont L; Roy AJ; Chamova T; Guergueltcheva V; Chan S; Korngut L; Campbell C; Dai Y; Wang J; Barišić N; Brabec P; Lahdetie J; Walter MC; Schreiber-Katz O; Karcagi V; Garami M; Viswanathan V; Bayat F; Buccella F; Kimura E; Koeks Z; van den Bergen JC; Rodrigues M; Roxburgh R; Lusakowska A; Kostera-Pruszczyk A; Zimowski J; Santos R; Neagu E; Artemieva S; Rasic VM; Vojinovic D; Posada M; Bloetzer C; Jeannet PY; Joncourt F; Díaz-Manera J; Gallardo E; Karaduman AA; Topaloğlu H; El Sherif R; Stringer A; Shatillo AV; Martin AS; Peay HL; Bellgard MI; Kirschner J; Flanigan KM; Straub V; Bushby K; Verschuuren J; Aartsma-Rus A; Béroud C; Lochmüller H
    Hum Mutat; 2015 Apr; 36(4):395-402. PubMed ID: 25604253
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Direct Reprogramming of Human DMD Fibroblasts into Myotubes for In Vitro Evaluation of Antisense-Mediated Exon Skipping and Exons 45-55 Skipping Accompanied by Rescue of Dystrophin Expression.
    Lee JJA; Saito T; Duddy W; Takeda S; Yokota T
    Methods Mol Biol; 2018; 1828():141-150. PubMed ID: 30171539
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Exon skipping induced by nonsense/frameshift mutations in DMD gene results in Becker muscular dystrophy.
    Okubo M; Noguchi S; Hayashi S; Nakamura H; Komaki H; Matsuo M; Nishino I
    Hum Genet; 2020 Feb; 139(2):247-255. PubMed ID: 31919629
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Clinical and molecular characterization of a cohort of patients with novel nucleotide alterations of the Dystrophin gene detected by direct sequencing.
    Magri F; Del Bo R; D'Angelo MG; Govoni A; Ghezzi S; Gandossini S; Sciacco M; Ciscato P; Bordoni A; Tedeschi S; Fortunato F; Lucchini V; Cereda M; Corti S; Moggio M; Bresolin N; Comi GP
    BMC Med Genet; 2011 Mar; 12():37. PubMed ID: 21396098
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.